From Randomized Trials to Real-World Data: The Evolution of Outcomes Research and the Path Forward
1,190 words, 6 minutes read time. Marc Berger Marc L. Berger, MD, is a semi-retired, part-time consultant and scientific advisor. Until July 2017, he was Vice President, Real World Data and Analytics at Pfizer, Inc. Marc has held senior-level positions in industry including Executive Vice President and Senior Scientist at OptumInsight; Vice President, Global Health…
